Total Payments
$845.89
2023 Payments
$321.09
Companies
13
Transactions
26
Medicare Patients
1,908
Medicare Billing
$233,100
Payment Breakdown by Category
Food & Beverage$766.90 (90.7%)
Education$78.99 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $766.90 | 25 | 90.7% |
| Education | $78.99 | 1 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $196.06 | 6 | $0 (2022) |
| Astellas Pharma US Inc | $114.88 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $82.75 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $82.74 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $78.99 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $71.96 | 4 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $61.26 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $40.58 | 2 | $0 (2018) |
| GENZYME CORPORATION | $33.93 | 2 | $0 (2023) |
| Axsome Therapeutics, Inc. | $24.02 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $321.09 | 13 | SANOFI-AVENTIS U.S. LLC ($78.99) |
| 2022 | $180.64 | 5 | GlaxoSmithKline, LLC. ($151.36) |
| 2021 | $24.92 | 2 | GlaxoSmithKline, LLC. ($24.92) |
| 2020 | $19.78 | 1 | GlaxoSmithKline, LLC. ($19.78) |
| 2018 | $299.46 | 5 | Astellas Pharma US Inc ($114.88) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Neurology | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Respiratory | ||||||
| 10/03/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $78.99 | General |
| Category: Immunology | ||||||
| 09/05/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Immunology | ||||||
| 08/29/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/07/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: General - Pain Management_NMD | ||||||
| 07/18/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/20/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Immunology | ||||||
| 05/24/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Respiratory | ||||||
| 03/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Respiratory | ||||||
| 01/24/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PULMONOLOGY | ||||||
| 10/27/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $122.03 | General |
| 09/13/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Respiratory | ||||||
| 08/16/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/15/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $20.24 | General |
| 02/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2018 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $61.26 | General |
| Category: VACCINE | ||||||
| 11/28/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $82.74 | General |
| Category: DIABETES | ||||||
| 06/19/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $114.88 | General |
| Category: UROLOGY | ||||||
| 04/16/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 263 | 498 | $72,950 | $37,854 |
| 2022 | 9 | 596 | 1,279 | $155,062 | $78,343 |
| 2021 | 8 | 566 | 1,047 | $117,322 | $61,784 |
| 2020 | 8 | 483 | 1,014 | $103,602 | $55,120 |
Total Patients
1,908
Total Services
3,838
Medicare Billing
$233,100
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 132 | 298 | $37,340 | $19,123 | 51.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 56 | $9,520 | $5,902 | 62.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 58 | $10,325 | $5,598 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 61 | $7,015 | $3,715 | 53.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $8,750 | $3,516 | 40.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 235 | 639 | $79,150 | $37,021 | 46.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 128 | 141 | $24,594 | $15,458 | 62.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 99 | $17,285 | $8,243 | 47.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 80 | 82 | $11,822 | $6,867 | 58.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 97 | $11,160 | $6,113 | 54.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 21 | $7,288 | $3,298 | 45.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 30 | 30 | $1,995 | $984.09 | 49.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 34 | $1,360 | $347.64 | 25.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 12 | 136 | $408.00 | $11.51 | 2.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 288 | 545 | $66,300 | $32,197 | 48.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 86 | 93 | $15,915 | $10,346 | 65.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 46 | 78 | $13,450 | $6,640 | 49.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 62 | 67 | $8,777 | $5,661 | 64.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 84 | $9,520 | $5,573 | 58.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 30 | 30 | $1,800 | $1,051 | 58.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 30 | $1,200 | $303.08 | 25.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 12 | 120 | $360.00 | $12.40 | 3.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 243 | 459 | $51,075 | $27,078 | 53.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 70 | 75 | $13,410 | $7,915 | 59.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 54 | 91 | $15,425 | $7,688 | 49.8% |
About Dr. Gary Berg, D.O
Dr. Gary Berg, D.O is a Pulmonary Disease healthcare provider based in Madison Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083698997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Berg, D.O has received a total of $845.89 in payments from pharmaceutical and medical device companies, with $321.09 received in 2023. These payments were reported across 26 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($766.90).
As a Medicare-enrolled provider, Berg has provided services to 1,908 Medicare beneficiaries, totaling 3,838 services with total Medicare billing of $233,100. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Madison Heights, MI
- Active Since 12/05/2005
- Last Updated 12/11/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1083698997
Products in Payments
- DUPIXENT (Biological) $195.67
- MYRBETRIQ (Drug) $114.88
- JARDIANCE (Drug) $82.74
- GARDASIL (Biological) $61.26
- Utibron (Drug) $40.58
- NUCALA (Biological) $33.59
- BREZTRI (Drug) $31.68
- Sunosi (Drug) $24.02
- TEZSPIRE (Biological) $23.72
- GLASSIA (Biological) $20.63
- CHARTIS CATHETER (Device) $20.29
- TRELEGY ELLIPTA (Drug) $20.20
- AIRSUPRA (Drug) $16.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.